Capicua (CIC) mutations in gliomas are associated with MAPK activation exposing a potential therapeutic target | Caris Life Sciences
Portal
Order
Home / Research / Publications / Capicua (CIC) mutations in gliomas are associated with MAPK activation exposing a potential therapeutic target

Publications

Back

Capicua (CIC) mutations in gliomas are associated with MAPK activation exposing a potential therapeutic target

– Caris Life Sciences

Poster

Key Finding:

CIC mutations occur frequently in oligodendrogliomas and are associated with favorable prognostic markers. 

Download Publication

Discover
More

  • Spliceosome Mutations in Metastatic Breast Cancer An Analysis of a Decentralized Clinical Trial and Large Clinical Genomic Dataset

    – Caris Life Sciences

    Poster

    […]

  • Molecular landscape of HR+/HER2- male breast cancer (MaBC) compared with female breast cancer (FeBC)

    – Caris Life Sciences

    Poster

    […]
Learn More

Ready to Get Started on the Journey?

Name(Required)